Starling Oncology, Inc. Warrant
STLNW
11 hedge funds and large institutions have $195K invested in Starling Oncology, Inc. Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
106% more capital invested
Capital invested by funds: $94.9K → $195K (+$101K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.36% less ownership
Funds ownership: 4.65% → 4.28% (-0.36%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$11.9K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$7.56K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FL
FreeGulliver LLC
New Orleans,
Louisiana
|
-$501 |
| 2 |
CS
Clear Street
New York
|
-$32 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $83.4K | – | – | – |
|
|
DM
2
Deerfield Management
New York
| $64.1K | – | – | – |
|
|
DKCM
3
Davidson Kempner Capital Management
New York
| $16.4K | – | – | – |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $9.83K | +$7.56K | +119,249 | +165% |
|
|
5
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $9.63K | +$11.9K | +187,674 | New |
|
6
Man Group
London,
United Kingdom
| $4.56K | – | – | – |
|
7
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| $4.49K | – | – | – |
|
|
AGM
8
Alpine Global Management
New York
| $1.28K | – | – | – |
|
|
TCM
9
Tenor Capital Management
New York
| $1.28K | – | – | – |
|
|
CS
10
Clear Street
New York
| $314 | -$32 | -500 | -8% |
|
|
11
UBS Group
Zurich,
Switzerland
| $187 | +$41 | +649 | +21% |
|
|
FL
12
FreeGulliver LLC
New Orleans,
Louisiana
| – | -$501 | -18,500 | Closed |
|
STLNW Hedge Fund Activity: Q2 2025 in Review
11 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q2 2025, worth a combined $195K — up 106% from $94.9K a quarter earlier.
Fund positioning in STLNW was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $11.9K. The largest seller was FreeGulliver LLC, exiting entirely with an estimated $501 sold.
- 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $195K of Starling Oncology, Inc. Warrant stock for Q2 2025, up 106% quarter-over-quarter.
- 1 fund opened new Starling Oncology, Inc. Warrant positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest Starling Oncology, Inc. Warrant buyer in Q2 2025 was Toronto Dominion Bank, an estimated $11.9K added.
- The largest Starling Oncology, Inc. Warrant seller in Q2 2025 was FreeGulliver LLC, an estimated $501 sold.
Based on aggregated 13F filings for Q2 2025.